Clinical trial
A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in…
NCT00315705 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00315705 |
|---|---|
| Title | A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. |
| Official title | A Phase 1/2 Dose-Escalation Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Pediatric Patients With Refractory or Relapsed Acute Leukemias. |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Relapsed Leukemia |
| Intervention type | Drug |
| Interventions | clofarabine, Etoposide, Cyclophosphamide |
| Enrollment | 50 |
| Start date | Mar 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Apr 19, 2006 |
| Last update posted | Apr 14, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: